New article!

🙏 A big thank you to the Universitat Politècnica de Catalunya (UPC) members for this very nice article on the progress of our PERMEPSY project!

👏 Read here: https://lnkd.in/eEZYU3dy

🎯 As a reminder, one of the main objectives of PERMEPSY is to develop a predictive platform for the effectiveness of Metacognitive Training (MCT) for psychosis (Steffen Moritz), which will be freely accessible.

📊 As announced in the article, the predictive platform is powered by previous RCTs on MCT for psychosis, involving over 700 participants.

🔬The platform will soon be tested in a pilot clinical trial involving 250 people with #schizophrenia across 🇪🇸Spain, 🇩🇪Germany, 🇵🇱Poland, 🇫🇷France, and 🇨🇱Chile.

📝We will, of course, keep you informed of progress. In the meantime, we hope that we will soon be able to share with you the literature reviews and meta-analyses on MCT written by our team, which are currently under review.

📢Stay tuned!

Share the Post:

Related Posts

First Poster!

👏 First poster presentation to Journées Neurosciences Psychiatrie Neurologie in Paris by our team member – Adrien Goncalves! 📝 Results of a systematic review and

Read More »

SIRS 2024

PERMEPSY at the Annual Congress of the Schizophrenia International Research Society 3-7 April 2024

Read More »